Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
Titel:
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
Auteur:
Subbiah, V. Kreitman, R.J. Wainberg, Z.A. Cho, J.Y. Schellens, J.H.M. Soria, J.C. Wen, P.Y. Zielinski, C.C. Cabanillas, M.E. Boran, A. Ilankumaran, P. Burgess, P. Romero Salas, T. Keam, B.